 | • レポートコード：GIR-107A14294 • 出版社/出版日：GlobalInfoResearch / 2021年7月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、感染性ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。感染性ワクチンの種類別市場規模（予防ワクチン、治療ワクチン）、用途別市場規模（成人、小児科）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・感染性ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：CSL Limited (Australia)、Bavarian Nordic (Denmark)、GlaxoSmithKline plc. (U.K.)、Emergent Bio Solutions Inc. (U.S.)、MedImmune LLC (U.S.)、Johnson and Johnson (U.S.)、Novartis AG (Switzerland)、Merck and Company (U.S.)、Sanofi Pasteur (France)、Pfizer Inc. (U.S.) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：予防ワクチン、治療ワクチン ・用途別分析2016年-2026年：成人、小児科 ・感染性ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・感染性ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・感染性ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・感染性ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・感染性ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Infectious Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Infectious Vaccines size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Infectious Vaccines market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Infectious Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Preventive Vaccine
Therapeutic Vaccine
Market segment by Application can be divided into
Adults
Pediatrics
The key market players for global Infectious Vaccines market are listed below:
CSL Limited (Australia)
Bavarian Nordic (Denmark)
GlaxoSmithKline plc. (U.K.)
Emergent Bio Solutions Inc. (U.S.)
MedImmune LLC (U.S.)
Johnson and Johnson (U.S.)
Novartis AG (Switzerland)
Merck and Company (U.S.)
Sanofi Pasteur (France)
Pfizer Inc. (U.S.)
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Infectious Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Infectious Vaccines, with price, sales, revenue and global market share of Infectious Vaccines from 2019 to 2021.
Chapter 3, the Infectious Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Infectious Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Infectious Vaccines market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Infectious Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Infectious Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Infectious Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Preventive Vaccine
1.2.3 Therapeutic Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Infectious Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Adults
1.3.3 Pediatrics
1.4 Global Infectious Vaccines Market Size & Forecast
1.4.1 Global Infectious Vaccines Sales in Value (2016-2026))
1.4.2 Global Infectious Vaccines Sales in Volume (2016-2026)
1.4.3 Global Infectious Vaccines Price by Type (2016-2026) & (USD/Unit)
1.5 Global Infectious Vaccines Production Capacity Analysis
1.5.1 Global Infectious Vaccines Total Production Capacity (2016-2026)
1.5.2 Global Infectious Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Infectious Vaccines Market Drivers
1.6.2 Infectious Vaccines Market Restraints
1.6.3 Infectious Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 CSL Limited (Australia)
2.1.1 CSL Limited (Australia) Details
2.1.2 CSL Limited (Australia) Major Business
2.1.3 CSL Limited (Australia) Infectious Vaccines Product and Services
2.1.4 CSL Limited (Australia) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bavarian Nordic (Denmark)
2.2.1 Bavarian Nordic (Denmark) Details
2.2.2 Bavarian Nordic (Denmark) Major Business
2.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Product and Services
2.2.4 Bavarian Nordic (Denmark) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 GlaxoSmithKline plc. (U.K.)
2.3.1 GlaxoSmithKline plc. (U.K.) Details
2.3.2 GlaxoSmithKline plc. (U.K.) Major Business
2.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product and Services
2.3.4 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Emergent Bio Solutions Inc. (U.S.)
2.4.1 Emergent Bio Solutions Inc. (U.S.) Details
2.4.2 Emergent Bio Solutions Inc. (U.S.) Major Business
2.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product and Services
2.4.4 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 MedImmune LLC (U.S.)
2.5.1 MedImmune LLC (U.S.) Details
2.5.2 MedImmune LLC (U.S.) Major Business
2.5.3 MedImmune LLC (U.S.) Infectious Vaccines Product and Services
2.5.4 MedImmune LLC (U.S.) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Johnson and Johnson (U.S.)
2.6.1 Johnson and Johnson (U.S.) Details
2.6.2 Johnson and Johnson (U.S.) Major Business
2.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Product and Services
2.6.4 Johnson and Johnson (U.S.) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Novartis AG (Switzerland)
2.7.1 Novartis AG (Switzerland) Details
2.7.2 Novartis AG (Switzerland) Major Business
2.7.3 Novartis AG (Switzerland) Infectious Vaccines Product and Services
2.7.4 Novartis AG (Switzerland) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Merck and Company (U.S.)
2.8.1 Merck and Company (U.S.) Details
2.8.2 Merck and Company (U.S.) Major Business
2.8.3 Merck and Company (U.S.) Infectious Vaccines Product and Services
2.8.4 Merck and Company (U.S.) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Sanofi Pasteur (France)
2.9.1 Sanofi Pasteur (France) Details
2.9.2 Sanofi Pasteur (France) Major Business
2.9.3 Sanofi Pasteur (France) Infectious Vaccines Product and Services
2.9.4 Sanofi Pasteur (France) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Pfizer Inc. (U.S.)
2.10.1 Pfizer Inc. (U.S.) Details
2.10.2 Pfizer Inc. (U.S.) Major Business
2.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Product and Services
2.10.4 Pfizer Inc. (U.S.) Infectious Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Infectious Vaccines Sales by Manufacturer
3.1 Global Infectious Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Infectious Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Infectious Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Infectious Vaccines Manufacturer Market Share
3.4.2 Top 6 Infectious Vaccines Manufacturer Market Share
3.5 Global Infectious Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Infectious Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Infectious Vaccines Market Size by Region
4.1.1 Global Infectious Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global Infectious Vaccines Revenue by Region (2016-2026)
4.2 North America Infectious Vaccines Revenue (2016-2026)
4.3 Europe Infectious Vaccines Revenue (2016-2026)
4.4 Asia-Pacific Infectious Vaccines Revenue (2016-2026)
4.5 South America Infectious Vaccines Revenue (2016-2026)
4.6 Middle East and Africa Infectious Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Infectious Vaccines Sales in Volume by Type (2016-2026)
5.2 Global Infectious Vaccines Revenue by Type (2016-2026)
5.3 Global Infectious Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Infectious Vaccines Sales in Volume by Application (2016-2026)
6.2 Global Infectious Vaccines Revenue by Application (2016-2026)
6.3 Global Infectious Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Infectious Vaccines Sales by Type (2016-2026)
7.2 North America Infectious Vaccines Sales by Application (2016-2026)
7.3 North America Infectious Vaccines Market Size by Country
7.3.1 North America Infectious Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America Infectious Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Infectious Vaccines Sales by Type (2016-2026)
8.2 Europe Infectious Vaccines Sales by Application (2016-2026)
8.3 Europe Infectious Vaccines Market Size by Country
8.3.1 Europe Infectious Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe Infectious Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Infectious Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific Infectious Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific Infectious Vaccines Market Size by Region
9.3.1 Asia-Pacific Infectious Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Infectious Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Infectious Vaccines Sales by Type (2016-2026)
10.2 South America Infectious Vaccines Sales by Application (2016-2026)
10.3 South America Infectious Vaccines Market Size by Country
10.3.1 South America Infectious Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America Infectious Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Infectious Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa Infectious Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa Infectious Vaccines Market Size by Country
11.3.1 Middle East & Africa Infectious Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Infectious Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Infectious Vaccines Typical Distributors
12.3 Infectious Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Infectious Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Infectious Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. CSL Limited (Australia) Basic Information, Manufacturing Base and Competitors
Table 4. CSL Limited (Australia) Major Business
Table 5. CSL Limited (Australia) Infectious Vaccines Product and Services
Table 6. CSL Limited (Australia) Infectious Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bavarian Nordic (Denmark) Basic Information, Manufacturing Base and Competitors
Table 8. Bavarian Nordic (Denmark) Major Business
Table 9. Bavarian Nordic (Denmark) Infectious Vaccines Product and Services
Table 10. Bavarian Nordic (Denmark) Infectious Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. GlaxoSmithKline plc. (U.K.) Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline plc. (U.K.) Major Business
Table 13. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product and Services
Table 14. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Emergent Bio Solutions Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 16. Emergent Bio Solutions Inc. (U.S.) Major Business
Table 17. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product and Services
Table 18. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. MedImmune LLC (U.S.) Basic Information, Manufacturing Base and Competitors
Table 20. MedImmune LLC (U.S.) Major Business
Table 21. MedImmune LLC (U.S.) Infectious Vaccines Product and Services
Table 22. MedImmune LLC (U.S.) Infectious Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Johnson and Johnson (U.S.) Basic Information, Manufacturing Base and Competitors
Table 24. Johnson and Johnson (U.S.) Major Business
Table 25. Johnson and Johnson (U.S.) Infectious Vaccines Product and Services
Table 26. Johnson and Johnson (U.S.) Infectious Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Novartis AG (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 28. Novartis AG (Switzerland) Major Business
Table 29. Novartis AG (Switzerland) Infectious Vaccines Product and Services
Table 30. Novartis AG (Switzerland) Infectious Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Merck and Company (U.S.) Basic Information, Manufacturing Base and Competitors
Table 32. Merck and Company (U.S.) Major Business
Table 33. Merck and Company (U.S.) Infectious Vaccines Product and Services
Table 34. Merck and Company (U.S.) Infectious Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Sanofi Pasteur (France) Basic Information, Manufacturing Base and Competitors
Table 36. Sanofi Pasteur (France) Major Business
Table 37. Sanofi Pasteur (France) Infectious Vaccines Product and Services
Table 38. Sanofi Pasteur (France) Infectious Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Pfizer Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 40. Pfizer Inc. (U.S.) Major Business
Table 41. Pfizer Inc. (U.S.) Infectious Vaccines Product and Services
Table 42. Pfizer Inc. (U.S.) Infectious Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Infectious Vaccines Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Infectious Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Infectious Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Infectious Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Infectious Vaccines Production Site of Key Manufacturer
Table 48. Infectious Vaccines New Entrant and Capacity Expansion Plans
Table 49. Infectious Vaccines Mergers & Acquisitions in the Past Five Years
Table 50. Global Infectious Vaccines Sales by Region (2016-2021e) & (K Units)
Table 51. Global Infectious Vaccines Sales by Region (2021-2026) & (K Units)
Table 52. Global Infectious Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global Infectious Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 54. Global Infectious Vaccines Sales by Type (2016-2021e) & (K Units)
Table 55. Global Infectious Vaccines Sales by Type (2021-2026) & (K Units)
Table 56. Global Infectious Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global Infectious Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 58. Global Infectious Vaccines Price by Type (2016-2021e) & (USD/Unit)
Table 59. Global Infectious Vaccines Price by Type (2021-2026) & (USD/Unit)
Table 60. Global Infectious Vaccines Sales by Application (2016-2021e) & (K Units)
Table 61. Global Infectious Vaccines Sales by Application (2021-2026) & (K Units)
Table 62. Global Infectious Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global Infectious Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 64. Global Infectious Vaccines Price by Application (2016-2021e) & (USD/Unit)
Table 65. Global Infectious Vaccines Price by Application (2021-2026) & (USD/Unit)
Table 66. North America Infectious Vaccines Sales by Country (2016-2021e) & (K Units)
Table 67. North America Infectious Vaccines Sales by Country (2021-2026) & (K Units)
Table 68. North America Infectious Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America Infectious Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 70. North America Infectious Vaccines Sales by Type (2016-2021e) & (K Units)
Table 71. North America Infectious Vaccines Sales by Type (2021-2026) & (K Units)
Table 72. North America Infectious Vaccines Sales by Application (2016-2021e) & (K Units)
Table 73. North America Infectious Vaccines Sales by Application (2021-2026) & (K Units)
Table 74. Europe Infectious Vaccines Sales by Country (2016-2021e) & (K Units)
Table 75. Europe Infectious Vaccines Sales by Country (2021-2026) & (K Units)
Table 76. Europe Infectious Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe Infectious Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe Infectious Vaccines Sales by Type (2016-2021e) & (K Units)
Table 79. Europe Infectious Vaccines Sales by Type (2021-2026) & (K Units)
Table 80. Europe Infectious Vaccines Sales by Application (2016-2021e) & (K Units)
Table 81. Europe Infectious Vaccines Sales by Application (2021-2026) & (K Units)
Table 82. Asia-Pacific Infectious Vaccines Sales by Region (2016-2021e) & (K Units)
Table 83. Asia-Pacific Infectious Vaccines Sales by Region (2021-2026) & (K Units)
Table 84. Asia-Pacific Infectious Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific Infectious Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Infectious Vaccines Sales by Type (2016-2021e) & (K Units)
Table 87. Asia-Pacific Infectious Vaccines Sales by Type (2021-2026) & (K Units)
Table 88. Asia-Pacific Infectious Vaccines Sales by Application (2016-2021e) & (K Units)
Table 89. Asia-Pacific Infectious Vaccines Sales by Application (2021-2026) & (K Units)
Table 90. South America Infectious Vaccines Sales by Country (2016-2021e) & (K Units)
Table 91. South America Infectious Vaccines Sales by Country (2021-2026) & (K Units)
Table 92. South America Infectious Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America Infectious Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 94. South America Infectious Vaccines Sales by Type (2016-2021e) & (K Units)
Table 95. South America Infectious Vaccines Sales by Type (2021-2026) & (K Units)
Table 96. South America Infectious Vaccines Sales by Application (2016-2021e) & (K Units)
Table 97. South America Infectious Vaccines Sales by Application (2021-2026) & (K Units)
Table 98. Middle East & Africa Infectious Vaccines Sales by Country (2016-2021e) & (K Units)
Table 99. Middle East & Africa Infectious Vaccines Sales by Country (2021-2026) & (K Units)
Table 100. Middle East & Africa Infectious Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa Infectious Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Infectious Vaccines Sales by Type (2016-2021e) & (K Units)
Table 103. Middle East & Africa Infectious Vaccines Sales by Type (2021-2026) & (K Units)
Table 104. Middle East & Africa Infectious Vaccines Sales by Application (2016-2021e) & (K Units)
Table 105. Middle East & Africa Infectious Vaccines Sales by Application (2021-2026) & (K Units)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. Infectious Vaccines Typical Distributors
Table 109. Infectious Vaccines Typical Customers
List of Figures
Figure 1. Infectious Vaccines Picture
Figure 2. Global Infectious Vaccines Sales Market Share by Type in 2020
Figure 3. Preventive Vaccine
Figure 4. Therapeutic Vaccine
Figure 5. Global Infectious Vaccines Sales Market Share by Application in 2020
Figure 6. Adults
Figure 7. Pediatrics
Figure 8. Global Infectious Vaccines Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Infectious Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Infectious Vaccines Sales (2016-2026) & (K Units)
Figure 11. Global Infectious Vaccines Price by Type (2016-2026) & (USD/Unit)
Figure 12. Global Infectious Vaccines Production Capacity (2016-2026) & (K Units)
Figure 13. Global Infectious Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Infectious Vaccines Market Drivers
Figure 15. Infectious Vaccines Market Restraints
Figure 16. Infectious Vaccines Market Trends
Figure 17. Global Infectious Vaccines Sales Market Share by Manufacturer in 2020
Figure 18. Global Infectious Vaccines Revenue Market Share by Manufacturer in 2020
Figure 19. Infectious Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Infectious Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Infectious Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Infectious Vaccines Sales Market Share by Region (2016-2026)
Figure 23. Global Infectious Vaccines Revenue Market Share by Region (2016-2026)
Figure 24. North America Infectious Vaccines Revenue (2016-2026) & (USD Million)
Figure 25. Europe Infectious Vaccines Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Infectious Vaccines Revenue (2016-2026) & (USD Million)
Figure 27. South America Infectious Vaccines Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Infectious Vaccines Revenue (2016-2026) & (USD Million)
Figure 29. Global Infectious Vaccines Sales Market Share by Type (2016-2026)
Figure 30. Global Infectious Vaccines Revenue Market Share by Type (2016-2026)
Figure 31. Global Infectious Vaccines Price by Type (2016-2026) & (USD/Unit)
Figure 32. Global Infectious Vaccines Sales Market Share by Application (2016-2026)
Figure 33. Global Infectious Vaccines Revenue Market Share by Application (2016-2026)
Figure 34. Global Infectious Vaccines Price by Application (2016-2026) & (USD/Unit)
Figure 35. North America Infectious Vaccines Sales Market Share by Type (2016-2026)
Figure 36. North America Infectious Vaccines Sales Market Share by Application (2016-2026)
Figure 37. North America Infectious Vaccines Sales Market Share by Country (2016-2026)
Figure 38. North America Infectious Vaccines Revenue Market Share by Country (2016-2026)
Figure 39. United States Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Infectious Vaccines Sales Market Share by Type (2016-2026)
Figure 43. Europe Infectious Vaccines Sales Market Share by Application (2016-2026)
Figure 44. Europe Infectious Vaccines Sales Market Share by Country (2016-2026)
Figure 45. Europe Infectious Vaccines Revenue Market Share by Country (2016-2026)
Figure 46. Germany Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Infectious Vaccines Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Infectious Vaccines Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Infectious Vaccines Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Infectious Vaccines Revenue Market Share by Region (2016-2026)
Figure 55. China Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Infectious Vaccines Sales Market Share by Type (2016-2026)
Figure 62. South America Infectious Vaccines Sales Market Share by Application (2016-2026)
Figure 63. South America Infectious Vaccines Sales Market Share by Country (2016-2026)
Figure 64. South America Infectious Vaccines Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Infectious Vaccines Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Infectious Vaccines Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Infectious Vaccines Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Infectious Vaccines Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Infectious Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source